{
    "clinical_study": {
        "@rank": "53721", 
        "acronym": "LISW", 
        "arm_group": {
            "arm_group_label": "Shockwaves", 
            "description": "Low intensity linear focused shockwave device ('Renova')"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, pilot study for assessing the safety and efficacy of the treatments\n      performed with Renova (LI-ESWT) on symptomatic ED patients."
        }, 
        "brief_title": "Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Vasculogenic Erectile Dysfunction", 
        "condition_browse": {
            "mesh_term": "Erectile Dysfunction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Good general health\n\n          -  Vasculogenic ED for at least 6 months\n\n          -  International Index of Erectile Function 6 (IIEF-EF) between 11 to 25\n\n          -  Positive response to PDE5-I (able to penetrate on demand, Responders)\n\n          -  Negative response to PDE5-I (unable to penetrate on demand even with maximum PDE5-I\n             dosage,Non-responders)\n\n          -  Stable heterosexual relationship for more than 3 months\n\n        Exclusion Criteria:\n\n          -  Psychogenic ED\n\n          -  Neurological pathology\n\n          -  Hormonal pathology\n\n          -  Past radical prostatectomy\n\n          -  Recovering from cancer during last 5 years\n\n          -  Any unstable medical, psychiatric, spinal cord injury and penile anatomical   -\n             abnormalities\n\n          -  Clinically significant chronic hematological disease\n\n          -  Anti-androgens, oral or injectable androgens\n\n          -  Radiotherapy in pelvic region"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Sexual Medicine clinic"
            }
        }, 
        "enrollment": {
            "#text": "58", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02005731", 
            "org_study_id": "LSWT-004-EU"
        }, 
        "intervention": {
            "arm_group_label": "Shockwaves", 
            "intervention_name": "Low intensity linear focused shockwave device ('Renova')", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Low Intensity Shockwave", 
            "Extracorporeal shockwave therapy", 
            "Erectile dysfunction"
        ], 
        "lastchanged_date": "December 15, 2013", 
        "number_of_groups": "1", 
        "official_title": "A Prospective Pilot Study to Assess the Safety and Efficacy of Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' in Patients With Erectile Dysfunction", 
        "overall_official": {
            "affiliation": "Men's Health Clinic, Amstelland Hospital, Amsterdam, The Netherlands", 
            "last_name": "Cobi Reisman, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in the IIEF-EF (International Index of Erectile Function- Erectile Function Domain) score at 1, 3 and 6 months post treatment", 
            "safety_issue": "No", 
            "time_frame": "1, 3 and 6 months post treatment"
        }, 
        "reference": [
            {
                "PMID": "20451317", 
                "citation": "Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010 Aug;58(2):243-8. doi: 10.1016/j.eururo.2010.04.004. Epub 2010 May 6."
            }, 
            {
                "PMID": "22999553", 
                "citation": "Goyal NK, Garg M, Goel A. Re: Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study: Y. Vardi, B. Appel, A. Kilchevsky and I. Gruenwald. J Urol 2012; 187: 1769-1775. J Urol. 2012 Nov;188(5):2018-9. doi: 10.1016/j.juro.2012.07.052. Epub 2012 Sep 20."
            }, 
            {
                "PMID": "12152111", 
                "citation": "Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002 Aug;14(4):226-44. Review."
            }, 
            {
                "PMID": "21855209", 
                "citation": "Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011 Nov;60(5):1010-6. doi: 10.1016/j.eururo.2011.07.053. Epub 2011 Jul 30."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02005731"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in the SEP (Sexual Encounter Profile) Questions 2 and 3 at 1, 3 and 6 months post treatment", 
                "safety_issue": "No", 
                "time_frame": "1, 3 and 6 months post treatment"
            }, 
            {
                "measure": "Responses to the GAQ (Global Assessment questions) Questions 1 and 2 at 1, 3 and 6 months post treatment", 
                "safety_issue": "No", 
                "time_frame": "1, 3 and 6 months post treatment"
            }
        ], 
        "source": "Initia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Initia", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}